Skip to main content
Clinical Trials/NCT06976164
NCT06976164RecruitingNot Applicable

The Effects of Reflexo Therapy of Sole on Gestational Diabetes Mellitus

Kafrelsheikh University1 site in 1 country36 target enrollmentStarted: May 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
36
Locations
1
Primary Endpoint
Change in The Oral Glucose Tolerance Test.

Study Overview

Brief Summary

The purpose of this study will be to detect the effects of Reflexo therapy of sole on GDM.

Detailed Description

Gestational diabetes mellitus is considered a hazard factor for antenatal complications for both mother and fetus. It is characterized by glucose intolerance of variable degrees with the beginning or first recognition of pregnancy. It affects 14% of pregnancies worldwide, and it undergoes continuous changes in the diagnostic criteria, ethnicity and the population studied.

There is an increasing prevalence of diabetes mellitus, and its major metabolic disorder caused by the insulin secretion defect or insulin action defect resulting from a defect in insulin secretion, insulin action, or both. As a result, it will lead to chronic hyperglycemia associated with carbohydrates, protein, and fat disturbance.

In spite of the fact that the reason for gestational diabetes mellitus is still not fully understood, it is proposed that human placental lactogen has growth hormone-like actions, and that it causes lipolysis and thus increases the levels of circulating fatty acids that repress the action of insulin and cause insulin resistance in pregnant females which appear to play a crucial role in the pathogenesis of gestational diabetes mellitus.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 35 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •They were maternally aged between 20 and 35 years.
  • •The gestational age ranged from between 24 and 36 weeks.
  • •Their BMI didn't exceed 30 kg/m
  • •A singleton live fetus and not under stressful event.

Exclusion Criteria

  • •They had high-risk pregnancies.
  • •Bad obstetric situations.
  • •Diseases that could interfere with participation.
  • •Oral sedative administration.

Arms & Interventions

Experimental Group A

Experimental

Intervention: The standard antenatal care. (Procedure)

Experimental Group A

Experimental

Intervention: Foot reflexology. (Procedure)

Experimental Group B

Experimental

Intervention: The standard antenatal care. (Procedure)

Outcomes

Primary Outcomes

Change in The Oral Glucose Tolerance Test.

Time Frame: Change from Baseline Oral Glucose Tolerance Test at one month

Change in The Hemoglobin A1C Test.

Time Frame: Change from Baseline Hemoglobin A1C Test at one month

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yomna Ghanem

Demonstrator

Kafrelsheikh University

Study Sites (1)

Loading locations...

Similar Trials

Reflexo Therapy for Gestational Diabetes... | Clinical Trial